1 completed, 1 not yet recruiting. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Not yet recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow T Lymphoblastic Lymphoma: new trials by email Literature Review of T Lymphoblastic Lymphoma trials Research Report on T Lymphoblastic Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL) Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration - Stage II T Lymphoblastic Leukemia/Lymphoma, Stage III T Lymphoblastic Leukemia/Lymphoma | Phase 2 / Phase 3 | Not yet recruiting | Children's Oncology Group | 1708 | 2026-08-28 | 2026-07-30 |
| Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma Asparaginase, Cyclophosphamide, Cytarabine - T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma | Phase 3 | Completed | National Cancer Institute (NCI) | 1895 | 2007-01-30 | 2026-06-23 |
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (2) · Lymphoma (1)
Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Leukemia (2) · Leukemia, Lymphoid (2) · Lymphatic Diseases (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)
Asparaginase (2) · Calcium Dobesilate (2) · Cyclophosphamide (2) · Cytarabine (2) · Daunorubicin (2) · Dexamethasone (2) · Doxorubicin (2) · Mercaptopurine (2) · Methotrexate (2) · Prednisone (2) · Radiation (2) · Radiotherapy (2) · Thioguanine (2) · Vincristine (2) · auricularum (2)
Children's Oncology Group (1) · National Cancer Institute (NCI) (1)
Australia (1) · Canada (1) · New Zealand (1) · Switzerland (1) · United States (1)
Keith J August (1) · Stuart S Winter (1)
PMID 30138085, PMID 32552472, PMID 32813610, PMID 34302711, PMID 36603187, PMID 37556734, PMID 40533067, PMID 41592282, PMID 42085640
U10CA180886 (2), U10CA098543 (1)